Graves Light Lenhart Wealth, Inc. Charles River Laboratories International, Inc. Transaction History

Graves Light Lenhart Wealth, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $100,636 - $149,083	-493 Reduced 76.43%	152 $33,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $2,810 - $3,983	-11 Reduced 1.68%	645 $183,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $8,570 - $10,540	-23 Reduced 3.39%	656 $271,000
Q2 2021 Jul 12, 2021	SELL	$294.17 - $371.65 $5,883 - $7,433	-20 Reduced 2.86%	679 $251,000
Q1 2021 Apr 09, 2021	SELL	$249.67 - $299.48 $3,994 - $4,791	-16 Reduced 2.24%	699 $203,000
Q4 2020 Feb 04, 2021	BUY	$222.0 - $252.62 $158,730 - $180,623	715 New	715 $179,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Graves Light Lenhart Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Graves Light Lenhart Wealth, Inc. with notifications on news.